CLABF

Core One Labs Inc. CLABF

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode CLABF FNAM ENZN SRNE CNGGF DOSEF CTABF SIGY HLYK HAVLF
6M -99.98 % 0.00 % -29.96 % -36.36 % -36.50 % -90.43 % 0.00 % -37.82 % -1.13 % 280.00 %
YTD -99.98 % -75.00 % -76.62 % 75.00 % -47.08 % -63.27 % 0.00 % -45.71 % -2.78 % 90.00 %
1Y -99.99 % -75.00 % -79.95 % 75.00 % -46.37 % -63.27 % 0.00 % -45.71 % -22.22 % -63.46 %
3Y -100.00 % -99.97 % -84.41 % -82.72 % -95.11 % -77.07 % -98.89 % 584.00 % -68.18 % -95.57 %
5Y -100.00 % -99.98 % -83.49 % -98.36 % -98.71 % -92.63 % -99.99 % 17.93 % -84.78 % -99.99 %
10Y -100.00 % -99.99 % -95.01 % -98.60 % -98.71 % -92.63 % -100.00 % 17.93 % -95.00 % -99.99 %
From the beginning -100.00 % -100.00 % -96.95 % -98.38 % -98.71 % -92.63 % -100.00 % 17.93 % -95.00 % -99.99 %

Dividend

Enzon Pharmaceuticals, Inc.